Immunome Inc.
IMNM
6 insider filings · Latest: May 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | May 19 7:56 AM | Jean Jacques BienaimeDirector | Purchase | 5,000 | $20.70 | $103.5K | 43,415(D) | View → |
| Apr 2, 2026 | Apr 3 7:48 PM | Jack HigginsChief Scientific Officer | Sale | 9,438 | $21.64 | $204.2K | 22,000(D) | View → |
| Apr 2, 2026 | Apr 3 7:46 PM | Max RosettChief Financial Officer | Sale | 65,000 | $21.92 | $1.4M | 54,037(D) | View → |
| Mar 27, 2026 | Mar 31 7:11 AM | Clay B SiegallDirector, President and CEO | Purchase | 25,450 | $19.67 | $500.6K | 690,704(D) | View → |
| Mar 23, 2026 | Mar 23 9:23 PM | WAGENHEIM PHILIPDirector | Sale | 28,200 | $20.65 | $582.3K | 341,147(D) | View → |
| Mar 20, 2026 | Mar 23 9:23 PM | WAGENHEIM PHILIPDirector | Sale | 36,800 | $20.47 | $753.3K | 369,347(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Apr 3 7:46 PM | Max RosettChief Financial Officer | Option Exercise | 71,561 | $1.35 | 0(D) | View → |